Jianyu Yu

537 total citations
25 papers, 349 citations indexed

About

Jianyu Yu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Jianyu Yu has authored 25 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cancer Research and 9 papers in Immunology. Recurrent topics in Jianyu Yu's work include Peroxisome Proliferator-Activated Receptors (6 papers), Cancer, Lipids, and Metabolism (5 papers) and Immune cells in cancer (4 papers). Jianyu Yu is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (6 papers), Cancer, Lipids, and Metabolism (5 papers) and Immune cells in cancer (4 papers). Jianyu Yu collaborates with scholars based in United States, China and Hong Kong. Jianyu Yu's co-authors include Jin-Qing Liu, Xue‐Feng Bai, Fatemeh Talebian, Jiajun Du, Liguang Wang, Jianmin Zhu, Aiyan Hu, Hongchang Shen, Jun Xu and Jiajun Du and has published in prestigious journals such as The Journal of Immunology, Hepatology and Cancer Research.

In The Last Decade

Jianyu Yu

24 papers receiving 345 citations

Peers

Jianyu Yu
Bart Krist Poland
D. Schulz Germany
Tomasz Adamus United States
Matheus P. Pereira United States
Sabine Galland Switzerland
Joo Hyoung Lee United States
Bart Krist Poland
Jianyu Yu
Citations per year, relative to Jianyu Yu Jianyu Yu (= 1×) peers Bart Krist

Countries citing papers authored by Jianyu Yu

Since Specialization
Citations

This map shows the geographic impact of Jianyu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianyu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianyu Yu more than expected).

Fields of papers citing papers by Jianyu Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianyu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianyu Yu. The network helps show where Jianyu Yu may publish in the future.

Co-authorship network of co-authors of Jianyu Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianyu Yu. A scholar is included among the top collaborators of Jianyu Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianyu Yu. Jianyu Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avellino, Anthony M., Xingshan Jiang, Michael Lee, et al.. (2025). An Olive Oil–Based High-Fat Diet Promotes Obesity-Driven Metastasis of Triple-Negative Breast Cancer. Cancer Research. 85(24). 5015–5032. 1 indexed citations
2.
Jiang, Xingshan, Yiqin Xiong, Jianyu Yu, et al.. (2025). Expression profiles of FABP4 and FABP5 in breast cancer: clinical implications and perspectives. Discover Oncology. 16(1). 357–357. 3 indexed citations
3.
Bai, Shuang, et al.. (2025). DCAF13 influences breast cancer chemotherapy resistance through metabolic reprogramming by regulating c-Myc expression. Medical Oncology. 42(5). 178–178. 1 indexed citations
4.
Yu, Jianyu, Jiaqing Hao, Matthew S. Yorek, et al.. (2025). FABP5 in skin macrophages mediates saturated fat-induced IL-1β signaling in psoriatic inflammation. Cell Reports. 44(9). 116254–116254. 2 indexed citations
5.
Yorek, Matthew S., Xingshan Jiang, Jiaqing Hao, et al.. (2024). FABP4-mediated lipid accumulation and lipolysis in tumor-associated macrophages promote breast cancer metastasis. eLife. 13. 7 indexed citations
6.
Yu, Jianyu, Jiaqing Hao, Matthew S. Yorek, et al.. (2024). Determination of the FABP5 expression profile in skin lesions of an IMQ-induced psoriasis mouse model using flow cytometry. STAR Protocols. 5(2). 103018–103018. 1 indexed citations
7.
Hao, Jiaqing, Rong Jin, Yanmei Yi, et al.. (2024). Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancer. Breast Cancer Research. 26(1). 119–119. 6 indexed citations
8.
Yorek, Matthew S., Xingshan Jiang, Jiaqing Hao, et al.. (2024). FABP4-mediated lipid accumulation and lipolysis in tumor-associated macrophages promote breast cancer metastasis. eLife. 13. 7 indexed citations
9.
Zhu, Jianmin, Jianyu Yu, Aiyan Hu, et al.. (2023). IL-27 Gene Therapy Induces Stat3-Mediated Expansion of CD11b+Gr1+ Myeloid Cells and Promotes Accumulation of M1 Macrophages in the Tumor Microenvironment. The Journal of Immunology. 211(5). 895–902. 4 indexed citations
10.
Li, Shenglan, Can Wang, Jinyi Chen, et al.. (2023). Signaling pathways in brain tumors and therapeutic interventions. Signal Transduction and Targeted Therapy. 8(1). 8–8. 53 indexed citations
11.
Jin, Rong, Jiaqing Hao, Jianyu Yu, et al.. (2023). Role of FABP5 in T Cell Lipid Metabolism and Function in the Tumor Microenvironment. Cancers. 15(3). 657–657. 21 indexed citations
12.
Wang, Xiaomin, Jianyu Yu, Yi Zheng, et al.. (2023). PHF6 promotes the progression of endometrial carcinoma by increasing cancer cells growth and decreasing T‐cell infiltration. Journal of Cellular and Molecular Medicine. 27(5). 609–621. 4 indexed citations
13.
Hu, Aiyan, Jianmin Zhu, Chunxi Zeng, et al.. (2022). IL-27 Induces CCL5 Production by T Lymphocytes, Which Contributes to Antitumor Activity. The Journal of Immunology. 208(9). 2239–2245. 10 indexed citations
14.
Chen, Yuanting, et al.. (2022). Dental-derived mesenchymal stem cell sheets: a prospective tissue engineering for regenerative medicine. Stem Cell Research & Therapy. 13(1). 38–38. 39 indexed citations
15.
Talebian, Fatemeh, et al.. (2021). CD200 Blockade Modulates Tumor Immune Microenvironment but Fails to Show Efficacy in Inhibiting Tumor Growth in a Murine Model of Melanoma. Frontiers in Cell and Developmental Biology. 9. 739816–739816. 8 indexed citations
16.
Liu, Jin-Qing, Aiyan Hu, Jianmin Zhu, et al.. (2020). CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy. Advances in experimental medicine and biology. 1223. 155–165. 47 indexed citations
17.
Yu, Jianyu, Liguang Wang, Tiehong Zhang, et al.. (2015). Co-expression of β-arrestin1 and NF-кB is associated with cancer progression and poor prognosis in lung adenocarcinoma. Tumor Biology. 36(8). 6551–6558. 16 indexed citations
19.
Cao, Hongxin, et al.. (2014). Forced vital capacity predicts long-term survival for curative-resected NSCLC. Medical Oncology. 31(9). 146–146. 10 indexed citations
20.
Li, Xiaowei, Liguang Wang, Jianyu Yu, Jun Xu, & Jiajun Du. (2014). The genetic association between pri-miR-34b/c polymorphism (rs4938723 T > C) and susceptibility to cancers: evidence from published studies. Tumor Biology. 35(12). 12525–12534. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026